Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...
RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...
The US Food and Drug Administration (FDA) has put on hold all respiratory syncytial virus (RSV) vaccine trials involving infants (aged under 2 years) or RSV naive children aged 2-5 years, after a ...
Flu, Respiratory Syncytial Virus (RSV) and COVID-19 cases are on the rise in East Texas mostly impacting children. The Texas ...
HealthDay News — The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to a study published online Dec. 9 in JAMA Pediatrics.
An uptick in influenza, RSV and pediatric pneumonia cases has north Alabama health care providers concerned, and they are ...
Flu cases are surging across the commonwealth but for the youngest Pennsylvanians, another potentially dangerous respiratory virus is spreading quickly.
RSV is the leading cause of hospitalization in babies under the age of 1. Although it usually only causes mild cold-like symptoms in adults, the virus can be life-threatening for children ...